Karuna Therapeutics Inc (KRTX) - News Archive

Karuna Therapeutics, a leading biopharmaceutical company focused on developing innovative treatments for psychiatric and neurological disorders, has recently released its financial results for the fourth quarter and ful...

Bristol Myers Squibb Bolsters Neuroscience Portfolio with Karuna Therapeutics AcquisitionPrinceton, N.J. & Boston - In a strategic move to expand its neuroscience portfolio, pharmaceutical giant Bristol Myers Squibb (BM...

Karuna Therapeutics, a biopharmaceutical company dedicated to improving the lives of individuals with psychiatric and neurological disorders, has recently announced a significant development in their mission. The U.S. F...

Karuna Therapeutics Announces Positive Results from Phase 1b Trial of KarXT in Schizophrenia: Findings Yield Encouraging Outcomes on Ambulatory Blood Pressure MonitoringBoston-based biopharmaceutical company, Karuna The...